Initial and late resistance to imatinib in advanced gastrointestinal stromal tumors are predicted by different prognostic factors: A European Organisation for Research and Treatment of Cancer-Italian Sarcoma Group-Australasian Gastrointestinal Trials Group Study

Martine Van Glabbeke, Jaap Verweij, Paolo G. Casali, Axel Le Cesne, Peter Hohenberger, Isabelle Ray-Coquard, Marcus Schlemmer, Allan T. Van Oosterom, David Goldstein, Raf Sciot, Pancras C W Hogendoorn, Michelle Brown, Rossella Bertulli, Ian R. Judson

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Initial and late resistance to imatinib in advanced gastrointestinal stromal tumors are predicted by different prognostic factors: A European Organisation for Research and Treatment of Cancer-Italian Sarcoma Group-Australasian Gastrointestinal Trials Group Study'. Together they form a unique fingerprint.

Medicine & Life Sciences